Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9
|
| pubmed:dateCreated |
1998-9-22
|
| pubmed:abstractText |
Stroke is the third leading cause of death and the leading cause of adult disability in the United States. The clot-lysis drug tissue plasminogen activator is the only treatment that has been effective for acute stroke patients, yet there are significant limitations to its use and effectiveness. In this study retrograde transvenous neuroperfusion (RTN) was evaluated for its efficacy in reversing acute ischemia, preventing paralysis, and limiting pathological evidence of infarction in baboons.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0039-2499
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1912-6
|
| pubmed:dateRevised |
2003-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:9731618-Animals,
pubmed-meshheading:9731618-Arterial Occlusive Diseases,
pubmed-meshheading:9731618-Brain,
pubmed-meshheading:9731618-Brain Ischemia,
pubmed-meshheading:9731618-Cerebrovascular Disorders,
pubmed-meshheading:9731618-Disease Models, Animal,
pubmed-meshheading:9731618-Evoked Potentials, Somatosensory,
pubmed-meshheading:9731618-Male,
pubmed-meshheading:9731618-Neurologic Examination,
pubmed-meshheading:9731618-Papio,
pubmed-meshheading:9731618-Reperfusion,
pubmed-meshheading:9731618-Surgical Instruments,
pubmed-meshheading:9731618-Surgical Procedures, Operative
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Retrograde transvenous neuroperfusion: a back door treatment for stroke.
|
| pubmed:affiliation |
Division of Neurosurgery, University of California at Los Angeles School of Medicine, West Los Angeles Veterans Hospital, 90095-7039, USA. frazee@surgery.medsch.ucla.edu
|
| pubmed:publicationType |
Journal Article
|